COVID-19 – zdroje

V tomto článku naleznete seznam zdrojů, ze kterých jsem při sepisování článků o COVID-19 vycházel. Některé publikace byly v danou chvíli ještě ve fázi tzv. pre-printu, tedy neprošly ještě recenzním řízením. Jednalo se ovšem často o autory, kteří již o problematice COVID-19 publikovali či působí na předních vědeckých institucích.

  1. CENKO, Edina, Lina BADIMON, Raffaele BUGIARDINI, et al. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA). Cardiovascular Research [online]. 2021 [cit. 2021-9-24]. ISSN 0008-6363. Dostupné z: doi:10.1093/cvr/cvab298
  2. JAFARZADEH, Abdollah, Sara JAFARZADEH, Parvin NOZARI, Pejman MOKHTARI a Maryam NEMATI. Lymphopenia an important immunological abnormality in patients with COVID‐19: Possible mechanisms. Scandinavian Journal of Immunology [online]. 2021, 93(2) [cit. 2021-9-24]. ISSN 0300-9475. Dostupné z: doi:10.1111/sji.12967
  3. COVID vaccine immunity is waning — how much does that matter? https://www.nature.com/articles/d41586-021-02532-4
  4. Anti-SARS-CoV-2 Receptor Binding Domain Antibody Evolution after mRNA Vaccination. Alice Cho, Frauke Muecksch, Dennis Schaefer-Babajew, Zijun Wang, Shlomo Finkin, Christian Gaebler, Victor Ramos, Melissa Cipolla, Pilar Mendoza, Marianna Agudelo, Eva Bednarski, Justin DaSilva, Irina Shimeliovich, Juan Dizon, Mridushi Daga, Katrina Millard, Martina Turroja, Fabian Schmidt, Fengwen Zhang, Tarek Ben Tanfous, Mila Jankovic, Thiago Y. Oliveria, Anna Gazumyan, Marina Caskey, Paul D. Bieniasz, Theodora Hatziioannou, Michel C. Nussenzweig. bioRxiv 2021.07.29.454333; doi: https://doi.org/10.1101/2021.07.29.454333
  5. mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern. Rishi R. Goel, Mark M. Painter, Sokratis A. Apostolidis, Divij Mathew, Wenzhao Meng, Aaron M. Rosenfeld, Kendall A. Lundgreen, Arnold Reynaldi, David S. Khoury, Ajinkya Pattekar, Sigrid Gouma, Leticia Kuri-Cervantes, Philip Hicks, Sarah Dysinger, Amanda Hicks, Harsh Sharma, Sarah Herring, Scott Korte, Amy E. Baxter, Derek A. Oldridge, Josephine R. Giles, Madison E. Weirick, Christopher M. McAllister, Moses Awofolaju, Nicole Tanenbaum, Elizabeth M. Drapeau, Jeanette Dougherty, Sherea Long, Kurt D’Andrea, Jacob T. Hamilton, Maura McLaughlin, Justine C. Williams, Sharon Adamski, Oliva Kuthuru, The UPenn COVID Processing Unit, Ian Frank, Michael R. Betts, Laura A. Vella, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Scott E. Hensley, Miles P. Davenport, Paul Bates, Eline T. Luning Prak, Allison R. Greenplate, E. John Wherry. bioRxiv 2021.08.23.457229; doi: https://doi.org/10.1101/2021.08.23.457229
  6. GAEBLER, Christian, Zijun WANG, Julio C. C. LORENZI, et al. Evolution of antibody immunity to SARS-CoV-2. Nature [online]. 2021, 591(7851), 639-644 [cit. 2021-9-24]. ISSN 0028-0836. Dostupné z: doi:10.1038/s41586-021-03207-w
  7. TURNER, Jackson S., Jane A. O’HALLORAN, Elizaveta KALAIDINA, et al. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature [online]. 2021, 596(7870), 109-113 [cit. 2021-9-24]. ISSN 0028-0836. Dostupné z: doi:10.1038/s41586-021-03738-2
  8. VERMA, Amanda K., Kory J. LAVINE a Chieh-Yu LIN. Myocarditis after Covid-19 mRNA Vaccination. New England Journal of Medicine [online]. [cit. 2021-9-24]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMc2109975
  9. UJUETA, Francisco, Roshanak AZIMI, Matthew R. LOZIER, Robert POPPITI a Ari CIMENT. Lymphohistocytic myocarditis after Ad26.COV2.S viral vector COVID-19 vaccination. IJC Heart & Vasculature [online]. 2021, 36 [cit. 2021-9-24]. ISSN 23529067. Dostupné z: doi:10.1016/j.ijcha.2021.100869
  10. BAIRD, Jill K., Shawn M. JENSEN, Walter J. URBA, Bernard A. FOX a Jason R. BAIRD. SARS-CoV-2 Antibodies Detected in Mother’s Milk Post-Vaccination. Journal of Human Lactation [online]. 2021, 37(3), 492-498 [cit. 2021-9-24]. ISSN 0890-3344. Dostupné z: doi:10.1177/08903344211030168
  11. BUONSENSO, Danilo, Daniel MUNBLIT, Cristina DE ROSE, Dario SINATTI, Antonia RICCHIUTO, Angelo CARFI a Piero VALENTINI. Preliminary evidence on long COVID in children. Acta Paediatrica [online]. 2021, 110(7), 2208-2211 [cit. 2021-9-24]. ISSN 0803-5253. Dostupné z: doi:10.1111/apa.15870
  12. NASSERIE, Tahmina, Michael HITTLE a Steven N. GOODMAN. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19. JAMA Network Open [online]. 2021, 4(5) [cit. 2021-9-24]. ISSN 2574-3805. Dostupné z: doi:10.1001/jamanetworkopen.2021.11417
  13. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 April 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1april2021
  14. MUSIKANTOW, Daniel R., Mohit K. TURAGAM, Samantha SARTORI, et al. Atrial Fibrillation in Patients Hospitalized With COVID-19. JACC: Clinical Electrophysiology [online]. 2021, 7(9), 1120-1130 [cit. 2021-9-24]. ISSN 2405500X. Dostupné z: doi:10.1016/j.jacep.2021.02.009
  15. Reports of myocarditis and pericarditis following mRNA COVID-19 vaccines: A review of spontaneously reported data from the UK, Europe, and the US. Samantha Lane, Saad Shakir. medRxiv 2021.09.09.21263342; doi: https://doi.org/10.1101/2021.09.09.21263342
  16. Guidance Information for healthcare professionals on myocarditis and pericarditis following COVID-19 vaccination. Published 23 August 2021. https://www.gov.uk/government/publications/covid-19-vaccination-myocarditis-and-pericarditis-information-for-healthcare-professionals/information-for-healthcare-professionals-on-myocarditis-and-pericarditis-following-covid-19-vaccination
  17. Surveillance of Myocarditis (Inflammation of the Heart Muscle) Cases Between December 2020 and May 2021 (Including). https://www.gov.il/en/departments/news/01062021-03
  18. SHAY, David K., Tom T. SHIMABUKURO a Frank DESTEFANO. Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines. JAMA Cardiology [online]. [cit. 2021-9-24]. ISSN 2380-6583. Dostupné z: doi:10.1001/jamacardio.2021.2821
  19. BERGWERK, Moriah, Tal GONEN, Yaniv LUSTIG, et al. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. New England Journal of Medicine [online]. [cit. 2021-9-24]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2109072
  20. LASSEN, Mats Christian Højbjerg, Kristoffer Grundtvig SKAARUP, Jannie Nørgaard LIND, et al. Recovery of Cardiac Function Following COVID ‐19 ‐ ECHOVID ‐19: A Prospective Longitudinal Cohort Study. European Journal of Heart Failure [online]. [cit. 2021-9-24]. ISSN 1388-9842. Dostupné z: doi:10.1002/ejhf.2347
  21. CARRIZALES-SEPÚLVEDA, Edgar Francisco, Raymundo VERA-PINEDA, Ramiro FLORES-RAMÍREZ, Dalí Alejandro HERNÁNDEZ-GUAJARDO, Eduardo PÉREZ-CONTRERAS, Marcelo Mario LOZANO-IBARRA a Alejandro ORDAZ-FARÍAS. Echocardiographic Manifestations in COVID-19: A Review. Heart, Lung and Circulation [online]. 2021, 30(8), 1117-1129 [cit. 2021-9-24]. ISSN 14439506. Dostupné z: doi:10.1016/j.hlc.2021.02.004
  22. Comparison of children and young people admitted with SARS-CoV-2 across the UK in the first and second pandemic waves: prospective multicentre observational cohort study. Olivia V Swann, Louisa Pollock, Karl A Holden, Alasdair PS Munro, Aisleen Bennett, Thomas C Williams, Lance Turtle, Cameron J Fairfield, Thomas M Drake, Saul N Faust, Ian P Sinha, Damian Roland, Elizabeth Whittaker, Shamez N Ladhani, Jonathan S Nguyen-Van-Tam, Michelle Girvan, Chloe Donohue, Cara Donegan, Rebecca G Spencer, Hayley E Hardwick, Peter JM Openshaw, J Kenneth Baillie, Ewen M Harrison, Annemarie B Docherty, Malcolm G Semple. medRxiv 2021.09.14.21263567; doi: https://doi.org/10.1101/2021.09.14.21263567
  23. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. RECOVERY Collaborative Group, Peter W Horby, Marion Mafham, Leon Peto, Mark Campbell, Guilherme Pessoa-Amorim, Enti Spata, Natalie Staplin, Jonathan R Emberson, Benjamin Prudon, Paul Hine, Thomas Brown, Christopher A Green, Rahuldeb Sarkar, Purav Desai, Bryan Yates, Tom Bewick, Simon Tiberi, Tim Felton, J Kenneth Baillie, Maya H Buch, Lucy C Chappell, Jeremy N Day, Saul N Faust, Thomas Jaki, Katie Jeffery, Edmund Juszczak, Wei Shen Lim, Alan Montgomery, Andrew Mumford, Kathryn Rowan, Guy Thwaites, David M Weinreich, Richard Haynes, Martin J Landray. medRxiv 2021.06.15.21258542; doi: https://doi.org/10.1101/2021.06.15.21258542
  24. DOUGAN, Michael, Ajay NIRULA, Masoud AZIZAD, et al. Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19. New England Journal of Medicine [online]. [cit. 2021-9-24]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2102685
  25. SPINNER, Christoph D., Robert L. GOTTLIEB, Gerard J. CRINER, et al. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19. JAMA [online]. 2020, 324(11) [cit. 2021-9-24]. ISSN 0098-7484. Dostupné z: doi:10.1001/jama.2020.16349
  26. Session CIVP100 – CIV01 (epid/observational) Clinical Studies of Adult Infectious Diseases including Epidemiology and Clinical Trials. Remdesivir Treatment is Associated with Improved Survival in Hospitalized Patients with COVID-19. https://www.abstractsonline.com/pp8/#!/9286/presentation/11269
  27. OLENDER, Susan A, Katherine K PEREZ, Alan S GO, et al. Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care. Clinical Infectious Diseases [online]. 2020 [cit. 2021-9-24]. ISSN 1058-4838. Dostupné z: doi:10.1093/cid/ciaa1041
  28. BEIGEL, John H., Kay M. TOMASHEK, Lori E. DODD, et al. Remdesivir for the Treatment of Covid-19 — Final Report. New England Journal of Medicine [online]. 2020, 383(19), 1813-1826 [cit. 2021-9-24]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2007764
  29. PILISHVILI, Tamara, Ryan GIERKE, Katherine E. FLEMING-DUTRA, et al. Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel. New England Journal of Medicine [online]. [cit. 2021-9-24]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2106599
  30. ROSNER, Carolyn M., Leonard GENOVESE, Behnam N. TEHRANI, et al. Myocarditis Temporally Associated With COVID-19 Vaccination. Circulation [online]. 2021, 144(6), 502-505 [cit. 2021-9-24]. ISSN 0009-7322. Dostupné z: doi:10.1161/CIRCULATIONAHA.121.055891
  31. HALUSHKA, Marc K. a Richard S. VANDER HEIDE. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovascular Pathology [online]. 2021, 50 [cit. 2021-9-24]. ISSN 10548807. Dostupné z: doi:10.1016/j.carpath.2020.107300
  32. MCMURRAY, Jeremy C., Joseph W. MAY, Madeleine W. CUNNINGHAM a Olcay Y. JONES. Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis—A Critical Review of Its Pathogenesis and Treatment. Frontiers in Pediatrics [online]. 2020, 8 [cit. 2021-9-24]. ISSN 2296-2360. Dostupné z: doi:10.3389/fped.2020.626182
  33. ESCHER, Felicitas, Heiko PIETSCH, Ganna ALESHCHEVA, et al. Detection of viral SARS‐CoV‐2 genomes and histopathological changes in endomyocardial biopsies. ESC Heart Failure [online]. 2020, 7(5), 2440-2447 [cit. 2021-9-24]. ISSN 2055-5822. Dostupné z: doi:10.1002/ehf2.12805
  34. AGDAMAG, Arianne Clare C., Jonathan B. EDMISTON, Victoria CHARPENTIER, Mohammed CHOWDHURY, Meg FRASER, Valmiki R. MAHARAJ, Gary S. FRANCIS a Tamas ALEXY. Update on COVID-19 Myocarditis. Medicina [online]. 2020, 56(12) [cit. 2021-9-24]. ISSN 1648-9144. Dostupné z: doi:10.3390/medicina56120678
  35. Vaccinations inUnited Kingdom. https://coronavirus.data.gov.uk/details/vaccinations
  36. Research and analysis. Coronavirus vaccine – weekly summary of Yellow Card reporting. Updated 23 September 2021. https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting
  37. WISE, Jacqui. Covid-19: Should we be worried about reports of myocarditis and pericarditis after mRNA vaccines? BMJ [online]. [cit. 2021-9-24]. ISSN 1756-1833. Dostupné z: doi:10.1136/bmj.n1635
  38. JAIN, Supriya S., Jeremy M. STEELE, Brian FONSECA, et al. COVID-19 Vaccination-Associated Myocarditis in Adolescents. Pediatrics [online]. , pediatrics;peds.2021-053427v1 [cit. 2021-9-24]. ISSN 0031-4005. Dostupné z: doi:10.1542/peds.2021-053427
  39. The tangled history of mRNA vaccines. https://www.nature.com/articles/d41586-021-02483-w
  40. Questions and Answers about COVID-19 Vaccines. https://www.chop.edu/centers-programs/vaccine-education-center/making-vaccines/prevent-covid
  41. Evidence-based immunization information and tools for B.C. residents. https://immunizebc.ca/ask-us/questions/are-there-long-term-side-effects-caused-mrna-covid-19-vaccines-how-do-we-know
  42. How Do We Know the COVID-19 Vaccine Won’t Have Long-Term Side Effects? https://www.muhealth.org/our-stories/how-do-we-know-covid-19-vaccine-wont-have-long-term-side-effects
  43. Feature Article: Long-term Side Effects of COVID-19 Vaccine? What We Know. https://www.chop.edu/news/long-term-side-effects-covid-19-vaccine
  44. MUTHUKUMAR, Alagarraju, Madhusudhanan NARASIMHAN, Quan-Zhen LI, et al. In-Depth Evaluation of a Case of Presumed Myocarditis After the Second Dose of COVID-19 mRNA Vaccine. Circulation [online]. 2021, 144(6), 487-498 [cit. 2021-9-24]. ISSN 0009-7322. Dostupné z: doi:10.1161/CIRCULATIONAHA.121.056038
  45. LARSON, Kathryn F., Enrico AMMIRATI, Eric D. ADLER, et al. Myocarditis After BNT162b2 and mRNA-1273 Vaccination. Circulation [online]. 2021, 144(6), 506-508 [cit. 2021-9-24]. ISSN 0009-7322. Dostupné z: doi:10.1161/CIRCULATIONAHA.121.055913
  46. Rosenblum HG, Hadler SC, Moulia D, et al. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021. MMWR Morb Mortal Wkly Rep 2021;70:1094-1099. DOI: http://dx.doi.org/10.15585/mmwr.mm7032e4external
  47. DIAZ, George A., Guilford T. PARSONS, Sara K. GERING, Audrey R. MEIER, Ian V. HUTCHINSON a Ari ROBICSEK. Myocarditis and Pericarditis After Vaccination for COVID-19. JAMA [online]. [cit. 2021-9-24]. ISSN 0098-7484. Dostupné z: doi:10.1001/jama.2021.13443
  48. BARDA, Noam, Noa DAGAN, Yatir BEN-SHLOMO, et al. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. New England Journal of Medicine [online]. 2021, 385(12), 1078-1090 [cit. 2021-9-24]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2110475
  49. ADEGHATE, Ernest A., Nabil EID a Jaipaul SINGH. Mechanisms of COVID-19-induced heart failure: a short review. Heart Failure Reviews [online]. 2021, 26(2), 363-369 [cit. 2021-9-24]. ISSN 1382-4147. Dostupné z: doi:10.1007/s10741-020-10037-x
  50. KESICI, Selman, Hayrettin Hakan AYKAN, Diclehan ORHAN a Benan BAYRAKCI. Fulminant COVID-19-related myocarditis in an infant. European Heart Journal [online]. 2020, 41(31), 3021-3021 [cit. 2021-9-24]. ISSN 0195-668X. Dostupné z: doi:10.1093/eurheartj/ehaa515
  51. SANG, Charlie J., Alison BURKETT, Brittain HEINDL, Silvio H. LITOVSKY, Sumanth D. PRABHU, Paul V. BENSON a Indranee RAJAPREYAR. Cardiac pathology in COVID-19: a single center autopsy experience. Cardiovascular Pathology [online]. 2021, 54 [cit. 2021-9-24]. ISSN 10548807. Dostupné z: doi:10.1016/j.carpath.2021.107370
  52. LIMA-SETTA, Fernanda, Maria Clara de MAGALHÃES-BARBOSA, Gustavo RODRIGUES-SANTOS, et al. Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study. Jornal de Pediatria [online]. 2021, 97(3), 354-361 [cit. 2021-9-24]. ISSN 00217557. Dostupné z: doi:10.1016/j.jped.2020.10.008
  53. WU, Lin, Aislinn M. O’KANE, Hu PENG, Yaguang BI, Dagmara MOTRIUK-SMITH a Jun REN. SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management. Biochemical Pharmacology [online]. 2020, 178 [cit. 2021-9-24]. ISSN 00062952. Dostupné z: doi:10.1016/j.bcp.2020.114114
  54. QIN, Chuan, Luoqi ZHOU, Ziwei HU, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clinical Infectious Diseases [online]. 2020, 71(15), 762-768 [cit. 2021-9-24]. ISSN 1058-4838. Dostupné z: doi:10.1093/cid/ciaa248
  55. KEANE, Gerard a Tony DORMAN. Fatal pulmonary thromboembolism in asymptomatic COVID-19. Irish Journal of Medical Science (1971 -) [online]. [cit. 2021-9-24]. ISSN 0021-1265. Dostupné z: doi:10.1007/s11845-021-02735-8
  56. TUCKER, Nathan R., Mark CHAFFIN, Kenneth C. BEDI JR, et al. Myocyte Specific Upregulation of ACE2 in Cardiovascular Disease: Implications for SARS-CoV-2 Mediated Myocarditis. Circulation [online]. [cit. 2021-9-24]. ISSN 0009-7322. Dostupné z: doi:10.1161/CIRCULATIONAHA.120.047911
  57. TAVAZZI, Guido, Carlo PELLEGRINI, Marco MAURELLI, et al. Myocardial localization of coronavirus in COVID‐19 cardiogenic shock. European Journal of Heart Failure [online]. 2020, 22(5), 911-915 [cit. 2021-9-24]. ISSN 1388-9842. Dostupné z: doi:10.1002/ejhf.1828
  58. TSCHÖPE, Carsten, Enrico AMMIRATI, Biykem BOZKURT, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nature Reviews Cardiology [online]. 2021, 18(3), 169-193 [cit. 2021-9-24]. ISSN 1759-5002. Dostupné z: doi:10.1038/s41569-020-00435-x
  59. EL SAHLY, Hana M., Lindsey R. BADEN, Brandon ESSINK, et al. Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase. New England Journal of Medicine [online]. [cit. 2021-9-24]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2113017
  60. SINGH, Balraj, Parminder KAUR, Leon CEDENO, Taulant BRAHIMI, Prem PATEL, Hartaj VIRK, Fayez SHAMOON a Manesh BIKKINA. COVID-19 mRNA Vaccine and Myocarditis. European Journal of Case Reports in Internal Medicine [online]. 2021 [cit. 2021-9-24]. ISSN 2284-2594. Dostupné z: doi:10.12890/2021_002681
  61. SALAH, Husam M. a Jawahar L. MEHTA. COVID-19 Vaccine and Myocarditis. The American Journal of Cardiology [online]. 2021, 157, 146-148 [cit. 2021-9-24]. ISSN 00029149. Dostupné z: doi:10.1016/j.amjcard.2021.07.009
  62. https://www.worldometers.info/coronavirus/country/us/
  63. https://covid.cdc.gov/covid-data-tracker/#new-hospital-admissions
  64. Covid Vaccine Prompts Strong Immune Response in Younger Children, Pfizer Says. https://www.nytimes.com/2021/09/20/health/covid-children-vaccine-pfizer.html?referringSource=articleShare&fbclid=IwAR2Nyxkmq2vGhkboGiJodI0DhAOd8iJg_GWYi14HUrVmpm6Wpj5kYkHhJUs
  65. Self WH, Tenforde MW, Rhoads JP, et al. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021. MMWR Morb Mortal Wkly Rep 2021;70:1337–1343. DOI: http://dx.doi.org/10.15585/mmwr.mm7038e1
  66. https://www.worldometers.info/coronavirus/
  67. ISLAM, Nazrul, Sarah LEWINGTON, Rajesh K KHARBANDA, Jim DAVIES, Kinga A VÁRNAI a Ben LACEY. Sixty-day consequences of COVID-19 in patients discharged from hospital: an electronic health records study. European Journal of Public Health [online]. 2021, 31(2), 280-282 [cit. 2021-9-24]. ISSN 1101-1262. Dostupné z: doi:10.1093/eurpub/ckab009
  68. GÜNSTER, Christian, Reinhard BUSSE, Melissa SPODEN, et al. 6-month mortality and readmissions of hospitalized COVID-19 patients: A nationwide cohort study of 8,679 patients in Germany. PLOS ONE [online]. 2021, 16(8) [cit. 2021-9-24]. ISSN 1932-6203. Dostupné z: doi:10.1371/journal.pone.0255427
  69. DONNELLY, John P., Xiao Qing WANG, Theodore J. IWASHYNA a Hallie C. PRESCOTT. Readmission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System. JAMA [online]. 2021, 325(3) [cit. 2021-9-24]. ISSN 0098-7484. Dostupné z: doi:10.1001/jama.2020.21465
  70. CHOPRA, Vineet, Scott A. FLANDERS, Megan O’MALLEY, Anurag N. MALANI a Hallie C. PRESCOTT. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Annals of Internal Medicine [online]. 2021, 174(4), 576-578 [cit. 2021-9-24]. ISSN 0003-4819. Dostupné z: doi:10.7326/M20-5661
  71. https://covidtracking.com/data
  72. VILLAR, José, Shabina ARIFF, Robert B. GUNIER, et al. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection. JAMA Pediatrics [online]. 2021, 175(8) [cit. 2021-9-24]. ISSN 2168-6203. Dostupné z: doi:10.1001/jamapediatrics.2021.1050
  73. TRIMBOLI, Pierpaolo, Chiara CAMPONOVO, Lorenzo SCAPPATICCIO, Giuseppe BELLASTELLA, Arnoldo PICCARDO a Mario ROTONDI. Thyroid sequelae of COVID-19: a systematic review of reviews. Reviews in Endocrine and Metabolic Disorders [online]. 2021, 22(2), 485-491 [cit. 2021-9-24]. ISSN 1389-9155. Dostupné z: doi:10.1007/s11154-021-09653-1
  74. STEVENS, Jacob S., Kristen L. KING, Shelief Y. ROBBINS-JUAREZ, et al. High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy. PLOS ONE [online]. 2020, 15(12) [cit. 2021-9-24]. ISSN 1932-6203. Dostupné z: doi:10.1371/journal.pone.0244131
  75. COVID and the brain: researchers zero in on how damage occurs. https://www.nature.com/articles/d41586-021-01693-6?fbclid=IwAR0KorTlIX4Nkg8pR3d8zmmB3p_Exm_nh-f4kbN_58RiTcgnrsPaDx1A1O0
  76. Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset. https://elifesciences.org/articles/69336?fbclid=IwAR0u8DqL4OP6hXgFc3CETQ1rQ37ZkTNwq5vVwdsSqBkPBhwm9dLV5jJFNKE
  77. HILLIS, Susan D, H Juliette T UNWIN, Yu CHEN, et al. Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study. The Lancet [online]. 2021, 398(10298), 391-402 [cit. 2021-9-24]. ISSN 01406736. Dostupné z: doi:10.1016/S0140-6736(21)01253-8
  78. PROAL, Amy D. a Michael B. VANELZAKKER. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Frontiers in Microbiology [online]. 2021, 12 [cit. 2021-9-24]. ISSN 1664-302X. Dostupné z: doi:10.3389/fmicb.2021.698169
  79. NALBANDIAN, Ani, Kartik SEHGAL, Aakriti GUPTA, et al. Post-acute COVID-19 syndrome. Nature Medicine [online]. 2021, 27(4), 601-615 [cit. 2021-9-24]. ISSN 1078-8956. Dostupné z: doi:10.1038/s41591-021-01283-z
  80. BOWE, Benjamin, Yan XIE, Evan XU a Ziyad AL-ALY. Kidney Outcomes in Long COVID. Journal of the American Society of Nephrology [online]. [cit. 2021-9-24]. ISSN 1046-6673. Dostupné z: doi:10.1681/ASN.2021060734
  81. GIROLAMO, Raffaella Di, Asma KHALIL, Sara ALAMEDDINE, et al. Placental histopathology after SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis. American Journal of Obstetrics & Gynecology MFM [online]. 2021 [cit. 2021-9-24]. ISSN 25899333. Dostupné z: doi:10.1016/j.ajogmf.2021.100468
  82. Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distribution. Ruian Ke, Pamela P. Martinez, Rebecca L. Smith, Laura L. Gibson, Chad J. Achenbach, Sally McFall, Chao Qi, Joshua Jacob, Etienne Dembele, Camille Bundy, Lacy M. Simons, Egon A. Ozer, Judd F. Hultquist, Ramon Lorenzo-Redondo, Anita K. Opdycke, Claudia Hawkins, Robert L. Murphy, Agha Mirza, Madison Conte, Nicholas Gallagher, Chun Huai Luo, Junko Jarrett, Abigail Conte, Ruifeng Zhou, Mireille Farjo, Gloria Rendon, Christopher J. Fields, Leyi Wang, Richard Fredrickson, Melinda E. Baughman, Karen K. Chiu, Hannah Choi, Kevin R. Scardina, Alyssa N. Owens, John Broach, Bruce Barton, Peter Lazar, Matthew L. Robinson, Heba H. Mostafa, Yukari C. Manabe, Andrew Pekosz, David D. McManus, Christopher B. Brooke. medRxiv 2021.08.30.21262701; doi: https://doi.org/10.1101/2021.08.30.21262701
  83. ANTONELLI, Michela, Rose S PENFOLD, Jordi MERINO, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. The Lancet Infectious Diseases [online]. 2021 [cit. 2021-9-24]. ISSN 14733099. Dostupné z: doi:10.1016/S1473-3099(21)00460-6
  84. WELLINGHAUSEN, Nele, Dietmar PLONNÉ, Meike VOSS, Ralitsa IVANOVA, Reinhard FRODL a Susanne DEININGER. SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons. Journal of Clinical Virology [online]. 2020, 130 [cit. 2021-9-24]. ISSN 13866532. Dostupné z: doi:10.1016/j.jcv.2020.104542
  85. Children hospitalized with COVID-19 in U.S. hits record number. https://www.reuters.com/world/us/children-hospitalized-with-covid-19-us-hits-record-number-2021-08-14/
  86. Children and COVID-19: State-Level Data Report. https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/
  87. Delahoy MJ, Ujamaa D, Whitaker M, et al. Hospitalizations Associated with COVID-19 Among Children and Adolescents — COVID-NET, 14 States, March 1, 2020–August 14, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1255–1260. DOI: http://dx.doi.org/10.15585/mmwr.mm7036e2external.
  88. HEALTH AND SCIENCE
  89. Side effects from Covid vaccine boosters are similar to second dose, Pfizer tells FDA. https://www.cnbc.com/2021/09/15/covid-boosters-pfizer-releases-new-data-showing-side-effects-are-similar-to-second-dose.html
  90. FALSEY, Ann R., Robert W. FRENCK, Edward E. WALSH, et al. SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3. New England Journal of Medicine [online]. [cit. 2021-9-24]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMc2113468
  91. BAR-ON, Yinon M., Yair GOLDBERG, Micha MANDEL, et al. Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel. New England Journal of Medicine [online]. [cit. 2021-9-24]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2114255
  92. CROTTY, Shane. Hybrid immunity. Science [online]. 2021, 372(6549), 1392-1393 [cit. 2021-9-24]. ISSN 0036-8075. Dostupné z: doi:10.1126/science.abj2258
  93. LIN, Liangyu, Qing LI, Ying WANG a Yufang SHI. Syncytia formation during SARS-CoV-2 lung infection: a disastrous unity to eliminate lymphocytes. Cell Death & Differentiation [online]. 2021, 28(6), 2019-2021 [cit. 2021-9-25]. ISSN 1350-9047. Dostupné z: doi:10.1038/s41418-021-00795-y
  94. ARUNACHALAM, Prabhu S., Madeleine K. D. SCOTT, Thomas HAGAN, et al. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature [online]. 2021, 596(7872), 410-416 [cit. 2021-9-25]. ISSN 0028-0836. Dostupné z: doi:10.1038/s41586-021-03791-x
  95. Chang, S.E., Feng, A., Meng, W. et al. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun 12, 5417 (2021). https://doi.org/10.1038/s41467-021-25509-3
  96. Study links severe COVID-19 to increase in self-attacking antibodies. https://www.sciencedaily.com/releases/2021/09/210914082653.htm?fbclid=IwAR3_-WDRKcNcvW6U94-bRt6WGRF8aDHFG77UFNeQpPskIbzmAtvr3mTm7QU
  97. WANG, Yuxin, Zicheng DENG a Donglu SHI. How effective is a mask in preventing COVID‐19 infection? MEDICAL DEVICES & SENSORS [online]. 2021, 4(1) [cit. 2021-9-25]. ISSN 2573-802X. Dostupné z: doi:10.1002/mds3.10163
  98. RADER, Benjamin, Laura F WHITE, Michael R BURNS, et al. Mask-wearing and control of SARS-CoV-2 transmission in the USA: a cross-sectional study. The Lancet Digital Health [online]. 2021, 3(3), e148-e157 [cit. 2021-9-25]. ISSN 25897500. Dostupné z: doi:10.1016/S2589-7500(20)30293-4
  99. BROOKS, John T. a Jay C. BUTLER. Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2. JAMA [online]. 2021, 325(10) [cit. 2021-9-25]. ISSN 0098-7484. Dostupné z: doi:10.1001/jama.2021.1505
  100. Science Brief: SARS-CoV-2 and Surface (Fomite) Transmission for Indoor Community Environments. https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/surface-transmission.html
  101. COVID-19: Epidemiology, virology, and prevention. https://www.uptodate.com/contents/covid-19-epidemiology-virology-and-prevention
  102. THOMAS, Stephen J., Edson D. MOREIRA, Nicholas KITCHIN, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months. New England Journal of Medicine [online]. [cit. 2021-9-25]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2110345
  103. HIPPISLEY-COX, Julia, Martina PATONE, Xue W MEI, et al. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ [online]. [cit. 2021-9-25]. ISSN 1756-1833. Dostupné z: doi:10.1136/bmj.n1931
  104. BASTARD, Paul, Lindsey B. ROSEN, Qian ZHANG, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science [online]. 2020, 370(6515) [cit. 2021-9-25]. ISSN 0036-8075. Dostupné z: doi:10.1126/science.abd4585
  105. Intermediate and Long-Term Impact of COVID-19 on Cardiovascular Disease. https://www.acc.org/latest-in-cardiology/articles/2021/04/21/13/08/intermediate-and-long-term-impact-of-covid-19-on-cardiovascular-disease
  106. LEE, Ellen H., Kelsey L. KEPLER, Anita GEEVARUGHESE, Rachel PANETH-POLLAK, Marie S. DORSINVILLE, Stephanie NGAI a Kathleen H. REILLY. Race/Ethnicity Among Children With COVID-19–Associated Multisystem Inflammatory Syndrome. JAMA Network Open [online]. 2020, 3(11) [cit. 2021-9-25]. ISSN 2574-3805. Dostupné z: doi:10.1001/jamanetworkopen.2020.30280
  107. PAYNE, Amanda B., Zunera GILANI, Shana GODFRED-CATO, et al. Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2. JAMA Network Open [online]. 2021, 4(6) [cit. 2021-9-25]. ISSN 2574-3805. Dostupné z: doi:10.1001/jamanetworkopen.2021.16420
  108. FELDSTEIN, Leora R., Erica B. ROSE, Steven M. HORWITZ, et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. New England Journal of Medicine [online]. 2020, 383(4), 334-346 [cit. 2021-9-25]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2021680
  109. CHOW, Eric J. The Multisystem Inflammatory Syndrome in Adults With SARS-CoV-2 Infection—Another Piece of an Expanding Puzzle. JAMA Network Open [online]. 2021, 4(5) [cit. 2021-9-25]. ISSN 2574-3805. Dostupné z: doi:10.1001/jamanetworkopen.2021.10344
  110. KAUSHIK, Ashlesha, Sandeep GUPTA, Mangla SOOD, Seema SHARMA a Shikha VERMA. A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection. Pediatric Infectious Disease Journal [online]. 2020, 39(11), e340-e346 [cit. 2021-9-25]. ISSN 0891-3668. Dostupné z: doi:10.1097/INF.0000000000002888
  111. COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis. https://www.uptodate.com/contents/covid-19-multisystem-inflammatory-syndrome-in-children-mis-c-clinical-features-evaluation-and-diagnosis?sectionName=Echocardiography&topicRef=129614&anchor=H3146832116&source=see_link#H3146832116
  112. COVID-19: Multisystem inflammatory syndrome in children (MIS-C) management and Outcome. https://www.uptodate.com/contents/covid-19-multisystem-inflammatory-syndrome-in-children-mis-c-management-and-outcome
  113. ZUO, Yu, Shanea K. ESTES, Ramadan A. ALI, et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Science Translational Medicine [online]. 2020, 12(570) [cit. 2021-9-25]. ISSN 1946-6234. Dostupné z: doi:10.1126/scitranslmed.abd3876
  114. MUNBLIT, Daniel, Frances SIMPSON, Jeremy MABBITT, Audrey DUNN-GALVIN, Calum SEMPLE a John O WARNER. Legacy of COVID-19 infection in children: long-COVID will have a lifelong health/economic impact. Archives of Disease in Childhood [online]. , archdischild-2021-321882 [cit. 2021-9-25]. ISSN 0003-9888. Dostupné z: doi:10.1136/archdischild-2021-321882
  115. YONG, Shin Jie. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infectious Diseases [online]. 2021, 53(10), 737-754 [cit. 2021-9-25]. ISSN 2374-4235. Dostupné z: doi:10.1080/23744235.2021.1924397
  116. MOLTENI, Erika, Carole H SUDRE, Liane S CANAS, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. The Lancet Child & Adolescent Health [online]. 2021, 5(10), 708-718 [cit. 2021-9-25]. ISSN 23524642. Dostupné z: doi:10.1016/S2352-4642(21)00198-X
  117. THOMSON, Helen. Children with long covid. New Scientist [online]. 2021, 249(3323), 10-11 [cit. 2021-9-25]. ISSN 02624079. Dostupné z: doi:10.1016/S0262-4079(21)00303-1
  118. Long COVID and kids: scientists race to find answers. https://www.nature.com/articles/d41586-021-01935-7
  119. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/alldatarelatingtoprevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk
  120. Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020. MMWR Morb Mortal Wkly Rep 2020;69:993-998. DOI: http://dx.doi.org/10.15585/mmwr.mm6930e1
  121. COVID-19 rapid guideline: managing the long-term effects of COVID-19. https://www.nice.org.uk/guidance/ng188
  122. Lopez-Leon, S., Wegman-Ostrosky, T., Perelman, C. et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 11, 16144 (2021). https://doi.org/10.1038/s41598-021-95565-8
  123. DAVIS, Hannah E., Gina S. ASSAF, Lisa MCCORKELL, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine [online]. 2021, 38 [cit. 2021-9-25]. ISSN 25895370. Dostupné z: doi:10.1016/j.eclinm.2021.101019
  124. COVID-19: Cardiac manifestations in adults. https://www.uptodate.com/contents/covid-19-cardiac-manifestations-in-adults?sectionName=Putative%20causes&topicRef=127537&anchor=H3028899669&source=see_link#H3028899669
  125. DAUGHERTY, Sarah E, Yinglong GUO, Kevin HEATH, Micah C DASMARIÑAS, Karol Giuseppe JUBILO, Jirapat SAMRANVEDHYA, Marc LIPSITCH a Ken COHEN. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ [online]. [cit. 2021-9-25]. ISSN 1756-1833. Dostupné z: doi:10.1136/bmj.n1098
  126. AYOUBKHANI, Daniel, Kamlesh KHUNTI, Vahé NAFILYAN, Thomas MADDOX, Ben HUMBERSTONE, Ian DIAMOND a Amitava BANERJEE. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ [online]. [cit. 2021-9-25]. ISSN 1756-1833. Dostupné z: doi:10.1136/bmj.n693
  127. MURK, William, Monica GIERADA, Michael FRALICK, Andrew WECKSTEIN, Reyna KLESH a Jeremy A. RASSEN. Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study. Canadian Medical Association Journal [online]. 2021, 193(1), E10-E18 [cit. 2021-9-25]. ISSN 0820-3946. Dostupné z: doi:10.1503/cmaj.201686
  128. Boehmer TK, Kompaniyets L, Lavery AM, et al. Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021. MMWR Morb Mortal Wkly Rep 2021;70:1228–1232. DOI: http://dx.doi.org/10.15585/mmwr.mm7035e5
  129. Nishiga, M., Wang, D.W., Han, Y. et al. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol 17, 543–558 (2020). https://doi.org/10.1038/s41569-020-0413-9
  130. CLARK, Daniel E., Amar PARIKH, Jeffrey M. DENDY, et al. COVID-19 Myocardial Pathology Evaluation in Athletes With Cardiac Magnetic Resonance (COMPETE CMR). Circulation [online]. 2021, 143(6), 609-612 [cit. 2021-9-25]. ISSN 0009-7322. Dostupné z: doi:10.1161/CIRCULATIONAHA.120.052573
  131. DANIELS, Curt J., Saurabh RAJPAL, Joel T. GREENSHIELDS, et al. Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection. JAMA Cardiology [online]. 2021, 6(9) [cit. 2021-9-25]. ISSN 2380-6583. Dostupné z: doi:10.1001/jamacardio.2021.2065
  132. SHAFIABADI HASSANI, Neda, Hamed TALAKOOB, Hosein KARIM, Mohamad Hossein MOZAFARI BAZARGANY a Hadith RASTAD. Cardiac Magnetic Resonance Imaging Findings in 2954 COVID ‐19 Adult Survivors: A Comprehensive Systematic Review. Journal of Magnetic Resonance Imaging [online]. [cit. 2021-9-25]. ISSN 1053-1807. Dostupné z: doi:10.1002/jmri.27852
  133. OJHA, Vineeta, Mansi VERMA, Niraj N. PANDEY, et al. Cardiac Magnetic Resonance Imaging in Coronavirus Disease 2019 (COVID-19). Journal of Thoracic Imaging [online]. 2021, 36(2), 73-83 [cit. 2021-9-25]. ISSN 0883-5993. Dostupné z: doi:10.1097/RTI.0000000000000574
  134. KOTECHA, Tushar, Daniel S KNIGHT, Yousuf RAZVI, et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. European Heart Journal [online]. 2021, 42(19), 1866-1878 [cit. 2021-9-25]. ISSN 0195-668X. Dostupné z: doi:10.1093/eurheartj/ehab075
  135. PUNTMANN, Valentina O., M. Ludovica CARERJ, Imke WIETERS, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiology [online]. 2020, 5(11) [cit. 2021-9-25]. ISSN 2380-6583. Dostupné z: doi:10.1001/jamacardio.2020.3557
  136. DWECK, Marc R, Anda BULARGA, Rebecca T HAHN, et al. Global evaluation of echocardiography in patients with COVID-19. European Heart Journal – Cardiovascular Imaging [online]. 2020, 21(9), 949-958 [cit. 2021-9-25]. ISSN 2047-2404. Dostupné z: doi:10.1093/ehjci/jeaa178
  137. COVID-19: Evaluation and management of cardiac disease in adults. https://www.uptodate.com/contents/covid-19-evaluation-and-management-of-cardiac-disease-in-adults
  138. PELLICORI, Pierpaolo, Gemina DOOLUB, Chih Mun WONG, et al. COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database of Systematic Reviews [online]. 2021, 2021(3) [cit. 2021-9-25]. ISSN 14651858. Dostupné z: doi:10.1002/14651858.CD013879
  139. FOX, Steven, Rishik VASHISHT, Matthew SIUBA a Siddharth DUGAR. Evaluation and management of shock in patients with COVID-19. Cleveland Clinic Journal of Medicine [online]. [cit. 2021-9-25]. ISSN 0891-1150. Dostupné z: doi:10.3949/ccjm.87a.ccc052
  140. COVID-19: Cardiac manifestations in adults. https://www.uptodate.com/contents/covid-19-cardiac-manifestations-in-adults
  141. MALAS, Mahmoud B., Isaac N. NAAZIE, Nadin ELSAYED, Asma MATHLOUTHI, Rebecca MARMOR a Bryan CLARY. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis. EClinicalMedicine [online]. 2020, 29-30 [cit. 2021-9-25]. ISSN 25895370. Dostupné z: doi:10.1016/j.eclinm.2020.100639
  142. LOO, Joan, Daniella A SPITTLE a Michael NEWNHAM. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax [online]. 2021, 76(4), 412-420 [cit. 2021-9-25]. ISSN 0040-6376. Dostupné z: doi:10.1136/thoraxjnl-2020-216243
  143. CASTRO DOPICO, Xaquin, Sebastian OLS, Karin LORÉ a Gunilla B. KARLSSON HEDESTAM. Immunity to SARS‐CoV‐2 induced by infection or vaccination. Journal of Internal Medicine [online]. [cit. 2021-9-25]. ISSN 0954-6820. Dostupné z: doi:10.1111/joim.13372
  144. Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections. Sivan Gazit, Roei Shlezinger, Galit Perez, Roni Lotan, Asaf Peretz, Amir Ben-Tov, Dani Cohen, Khitam Muhsen, Gabriel Chodick, Tal Patalon. medRxiv 2021.08.24.21262415; doi: https://doi.org/10.1101/2021.08.24.21262415
  145. MCCALLUM, Matthew, Jessica BASSI, Anna DE MARCO, et al. SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern. Science [online]. 2021, 373(6555), 648-654 [cit. 2021-9-25]. ISSN 0036-8075. Dostupné z: doi:10.1126/science.abi7994
  146. GEERS, Daryl, Marc C. SHAMIER, Susanne BOGERS, et al. SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees. Science Immunology [online]. 2021, 6(59) [cit. 2021-9-25]. ISSN 2470-9468. Dostupné z: doi:10.1126/sciimmunol.abj1750
  147. LOPEZ BERNAL, Jamie, Nick ANDREWS, Charlotte GOWER, et al. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. New England Journal of Medicine [online]. 2021, 385(7), 585-594 [cit. 2021-9-25]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2108891
  148. WISNEWSKI, Adam V., Julian CAMPILLO LUNA, Carrie A. REDLICH a Aftab A. ANSARI. Human IgG and IgA responses to COVID-19 mRNA vaccines. PLOS ONE [online]. 2021, 16(6) [cit. 2021-9-25]. ISSN 1932-6203. Dostupné z: doi:10.1371/journal.pone.0249499
  149. WIDGE, Alicia T., Nadine G. ROUPHAEL, Lisa A. JACKSON, et al. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination. New England Journal of Medicine [online]. 2021, 384(1), 80-82 [cit. 2021-9-25]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMc2032195
  150. ZURAC, Sabina, Luciana NICHITA, Bogdan MATEESCU, et al. COVID‑19 vaccination and IgG and IgA antibody dynamics in healthcare workers. Molecular Medicine Reports [online]. 2021, 24(2) [cit. 2021-9-25]. ISSN 1791-2997. Dostupné z: doi:10.3892/mmr.2021.12217
  151. YU, Hai-qiong, Bao-qing SUN, Zhang-fu FANG, et al. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients. European Respiratory Journal [online]. 2020, 56(2) [cit. 2021-9-25]. ISSN 0903-1936. Dostupné z: doi:10.1183/13993003.01526-2020
  152. BAROUCH, Dan H., Kathryn E. STEPHENSON, Jerald SADOFF, et al. Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination. New England Journal of Medicine [online]. 2021, 385(10), 951-953 [cit. 2021-9-25]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMc2108829
  153. KRAUSE, Philip R., Thomas R. FLEMING, Ira M. LONGINI, et al. SARS-CoV-2 Variants and Vaccines. New England Journal of Medicine [online]. 2021, 385(2), 179-186 [cit. 2021-9-25]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMsr2105280
  154. WANG, Guo-Lin, Zhuang-Ye WANG, Li-Jun DUAN, et al. Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization. New England Journal of Medicine [online]. 2021, 384(24), 2354-2356 [cit. 2021-9-25]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMc2103022
  155. EDARA, Venkata-Viswanadh, Benjamin A. PINSKY, Mehul S. SUTHAR, et al. Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants. New England Journal of Medicine [online]. 2021, 385(7), 664-666 [cit. 2021-9-25]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMc2107799
  156. LUMLEY, Sheila F., Denise O’DONNELL, Nicole E. STOESSER, et al. Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers. New England Journal of Medicine [online]. 2021, 384(6), 533-540 [cit. 2021-9-25]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2034545
  157. BREUER, Adin, Allon RAPHAEL, Hagay STERN, et al. SARS‐CoV‐2 antibodies started to decline just four months after COVID‐19 infection in a paediatric population. Acta Paediatrica [online]. [cit. 2021-9-25]. ISSN 0803-5253. Dostupné z: doi:10.1111/apa.16031
  158. HANSEN, Christian Holm, Daniela MICHLMAYR, Sophie Madeleine GUBBELS, Kåre MØLBAK a Steen ETHELBERG. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. The Lancet [online]. 2021, 397(10280), 1204-1212 [cit. 2021-9-25]. ISSN 01406736. Dostupné z: doi:10.1016/S0140-6736(21)00575-4
  159. STERLIN, Delphine, Alexis MATHIAN, Makoto MIYARA, et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Science Translational Medicine [online]. 2021, 13(577) [cit. 2021-9-25]. ISSN 1946-6234. Dostupné z: doi:10.1126/scitranslmed.abd2223
  160. Tracking covid-19 excess deaths across Countries. https://www.economist.com/graphic-detail/coronavirus-excess-deaths-tracker
  161. MARSHALL, Mayme, Ian D. FERGUSON, Paul LEWIS, et al. Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination. Pediatrics [online]. 2021, 148(3) [cit. 2021-9-25]. ISSN 0031-4005. Dostupné z: doi:10.1542/peds.2021-052478
  162. KANDUC, Darja a Yehuda SHOENFELD. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine. Immunologic Research [online]. 2020, 68(5), 310-313 [cit. 2021-9-25]. ISSN 0257-277X. Dostupné z: doi:10.1007/s12026-020-09152-6
  163. COVID-19: Vaccines to prevent SARS-CoV-2 infection. https://www-uptodate-com.ezproxy.is.cuni.cz/contents/covid-19-vaccines-to-prevent-sars-cov-2-infection?search=covid%2019%20vaccine%20myocarditis&sectionRank=1&usage_type=default&anchor=H2581314898&source=machineLearning&selectedTitle=1~150&display_rank=1#H2581314898
  164. MONTGOMERY, Jay, Margaret RYAN, Renata ENGLER, et al. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military. JAMA Cardiology [online]. [cit. 2021-9-25]. ISSN 2380-6583. Dostupné z: doi:10.1001/jamacardio.2021.2833
  165. BOZKURT, Biykem, Ishan KAMAT a Peter J. HOTEZ. Myocarditis With COVID-19 mRNA Vaccines. Circulation [online]. 2021, 144(6), 471-484 [cit. 2021-9-25]. ISSN 0009-7322. Dostupné z: doi:10.1161/CIRCULATIONAHA.121.056135
  166. Coronavirus-associated molecular mimicry through homology to a SARS-CoV-2 peptide could be leading to susceptibility in patients with HLA-A*02:01 and HLA-A*24:02 serotypes. Yekbun Adiguzel. bioRxiv 2021.01.28.428642; doi: https://doi.org/10.1101/2021.01.28.428642
  167. COVID-19: Vaccine-induced immune thrombotic thrombocytopenia (VITT). https://www-uptodate-com.ezproxy.is.cuni.cz/contents/covid-19-vaccine-induced-immune-thrombotic-thrombocytopenia-vitt?search=covid%2019%20vaccine&source=search_result&selectedTitle=3~138&usage_type=default&display_rank=2
  168. HUNTER, Paul R. Thrombosis after covid-19 vaccination. BMJ [online]. [cit. 2021-9-25]. ISSN 1756-1833. Dostupné z: doi:10.1136/bmj.n958
  169. GREINACHER, Andreas, Thomas THIELE, Theodore E. WARKENTIN, Karin WEISSER, Paul A. KYRLE a Sabine EICHINGER. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. New England Journal of Medicine [online]. 2021, 384(22), 2092-2101 [cit. 2021-9-25]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2104840
  170. SHIMABUKURO, Tom T., Shin Y. KIM, Tanya R. MYERS, et al. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. New England Journal of Medicine [online]. 2021, 384(24), 2273-2282 [cit. 2021-9-25]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2104983
  171. DUTTA, Sulagna a Pallav SENGUPTA. SARS-CoV-2 and Male Infertility: Possible Multifaceted Pathology. Reproductive Sciences [online]. 2021, 28(1), 23-26 [cit. 2021-9-25]. ISSN 1933-7191. Dostupné z: doi:10.1007/s43032-020-00261-z
  172. Addressing anti-syncytin antibody levels, and fertility and breastfeeding concerns, following BNT162B2 COVID-19 mRNA Vaccination. Citra NZ Mattar, Winston Koh, Yiqi Seow, Shawn Hoon, Aparna Venkatesh, Pradip Dashraath, Li Min Lim, Judith Ong, Rachel Lee, Nuryanti Johana, Julie SL Yeo, David Chong, Lay-Kok Tan, Jerry Chan, Mahesh Choolani, Paul Anantharajah Tambyah. medRxiv 2021.05.23.21257686; doi: https://doi.org/10.1101/2021.05.23.21257686
  173. Fact check: Available mRNA vaccines do not target syncytin-1, a protein vital to successful pregnancies. https://www.reuters.com/article/uk-factcheck-syncytin-idUSKBN2A42S7
  174. GONZALEZ, Daniel C., Daniel E. NASSAU, Kajal KHODAMORADI, Emad IBRAHIM, Ruben BLACHMAN-BRAUN, Jesse ORY a Ranjith RAMASAMY. Sperm Parameters Before and After COVID-19 mRNA Vaccination. JAMA [online]. 2021, 326(3) [cit. 2021-9-25]. ISSN 0098-7484. Dostupné z: doi:10.1001/jama.2021.9976
  175. Do the mRNA vaccines cause infertility? (UPDATED*). https://www.icsi.org/covid-19-vaccine-faq/do-the-mrna-vaccines-cause-infertility/
  176. ALBERER, Martin, Ulrike GNAD-VOGT, Henoch Sangjoon HONG, et al. Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial. The Lancet [online]. 2017, 390(10101), 1511-1520 [cit. 2021-9-25]. ISSN 01406736. Dostupné z: doi:10.1016/S0140-6736(17)31665-3
  177. Miao, L., Zhang, Y. & Huang, L. mRNA vaccine for cancer immunotherapy. Mol Cancer 20, 41 (2021). https://doi.org/10.1186/s12943-021-01335-5
  178. Chaudhary, N., Weissman, D. & Whitehead, K.A. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat Rev Drug Discov (2021). https://doi.org/10.1038/s41573-021-00283-5
  179. Anand, P., Stahel, V.P. The safety of Covid-19 mRNA vaccines: a review. Patient Saf Surg 15, 20 (2021). https://doi.org/10.1186/s13037-021-00291-9
  180. ZHANG, Cuiling, Giulietta MARUGGI, Hu SHAN a Junwei LI. Advances in mRNA Vaccines for Infectious Diseases. Frontiers in Immunology [online]. 2019, 10 [cit. 2021-9-25]. ISSN 1664-3224. Dostupné z: doi:10.3389/fimmu.2019.00594
  181. Pardi, N., Hogan, M., Porter, F. et al. mRNA vaccines — a new era in vaccinology. Nat Rev Drug Discov 17, 261–279 (2018). https://doi.org/10.1038/nrd.2017.243
  182. FELDMAN, Robert A., Rainard FUHR, Igor SMOLENOV, et al. MRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials. Vaccine [online]. 2019, 37(25), 3326-3334 [cit. 2021-9-25]. ISSN 0264410X. Dostupné z: doi:10.1016/j.vaccine.2019.04.074
  183. BAHL, Kapil, Joe J. SENN, Olga YUZHAKOV, et al. Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses. Molecular Therapy [online]. 2017, 25(6), 1316-1327 [cit. 2021-9-25]. ISSN 15250016. Dostupné z: doi:10.1016/j.ymthe.2017.03.035
  184. Cavanaugh AM, Spicer KB, Thoroughman D, Glick C, Winter K. Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021. MMWR Morb Mortal Wkly Rep 2021;70:1081-1083. DOI: http://dx.doi.org/10.15585/mmwr.mm7032e1
  185. LEE, Grace M. The Importance of Context in Covid-19 Vaccine Safety. New England Journal of Medicine [online]. 2021, 385(12), 1138-1140 [cit. 2021-9-25]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMe2112543
  186. Risk for COVID-19 Infection, Hospitalization, and Death By Age Group. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-age.html
  187. CREECH, C. Buddy, Shannon C. WALKER a Robert J. SAMUELS. SARS-CoV-2 Vaccines. JAMA [online]. 2021, 325(13) [cit. 2021-9-25]. ISSN 0098-7484. Dostupné z: doi:10.1001/jama.2021.3199
  188. Kyriakidis, N.C., López-Cortés, A., González, E.V. et al. SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates. npj Vaccines 6, 28 (2021). https://doi.org/10.1038/s41541-021-00292-w
  189. JORDAN, S. C. Innate and adaptive immune responses to SARS‐CoV‐2 in humans: relevance to acquired immunity and vaccine responses. Clinical & Experimental Immunology [online]. 2021, 204(3), 310-320 [cit. 2021-9-25]. ISSN 0009-9104. Dostupné z: doi:10.1111/cei.13582
  190. Pan, Y., Jiang, X., Yang, L. et al. SARS-CoV-2-specific immune response in COVID-19 convalescent individuals. Sig Transduct Target Ther 6, 256 (2021). https://doi.org/10.1038/s41392-021-00686-1
  191. Immune responses and immunity to SARS-CoV-2. https://www.ecdc.europa.eu/en/covid-19/latest-evidence/immune-responses
  192. TAEFEHSHOKR, Nima, Sina TAEFEHSHOKR, Nima HEMMAT a Bryan HEIT. Covid-19: Perspectives on Innate Immune Evasion. Frontiers in Immunology [online]. 2020, 11 [cit. 2021-9-25]. ISSN 1664-3224. Dostupné z: doi:10.3389/fimmu.2020.580641
  193. SHAH, Vibhuti Kumar, Priyanka FIRMAL, Aftab ALAM, Dipyaman GANGULY a Samit CHATTOPADHYAY. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past. Frontiers in Immunology [online]. 2020, 11 [cit. 2021-9-25]. ISSN 1664-3224. Dostupné z: doi:10.3389/fimmu.2020.01949
  194. Tay, M.Z., Poh, C.M., Rénia, L. et al. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 20, 363–374 (2020). https://doi.org/10.1038/s41577-020-0311-8
  195. https://www.idsociety.org/covid-19-real-time-learning-network/therapeutics-and-interventions/immunomodulators/
  196. POPP, Maria, Miriam STEGEMANN, Maria-Inti METZENDORF, Susan GOULD, Peter KRANKE, Patrick MEYBOHM, Nicole SKOETZ a Stephanie WEIBEL. Ivermectin for preventing and treating COVID-19. Cochrane Database of Systematic Reviews [online]. 2021, 2021(8) [cit. 2021-9-25]. ISSN 14651858. Dostupné z: doi:10.1002/14651858.CD015017.pub2
  197. LAI, Chih-Cheng, Chao-Hsien CHEN, Cheng-Yi WANG, Kuang-Hung CHEN, Ya-Hui WANG a Po-Ren HSUEH. Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials. Journal of Antimicrobial Chemotherapy [online]. 2021, 76(8), 1962-1968 [cit. 2021-9-25]. ISSN 0305-7453. Dostupné z: doi:10.1093/jac/dkab093
  198. KALIL, Andre C., Thomas F. PATTERSON, Aneesh K. MEHTA, et al. Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. New England Journal of Medicine [online]. 2021, 384(9), 795-807 [cit. 2021-9-25]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2031994
  199. COVID-19: Epidemiology, clinical features, and prognosis of the critically ill adult. https://www-uptodate-com.ezproxy.is.cuni.cz/contents/covid-19-epidemiology-clinical-features-and-prognosis-of-the-critically-ill-adult?search=covid%2019%20mortality&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H3394835130
  200. ARMSTRONG, R. A., A. D. KANE, E. KURSUMOVIC, F. C. OGLESBY a T. M. COOK. Mortality in patients admitted to intensive care with COVID‐19: an updated systematic review and meta‐analysis of observational studies. Anaesthesia [online]. 2021, 76(4), 537-548 [cit. 2021-9-25]. ISSN 0003-2409. Dostupné z: doi:10.1111/anae.15425
  201. NGUYEN, Ninh T., Justine CHINN, Jeffry NAHMIAS, Sarah YUEN, Katharine A. KIRBY, Sam HOHMANN a Alpesh AMIN. Outcomes and Mortality Among Adults Hospitalized With COVID-19 at US Medical Centers. JAMA Network Open [online]. 2021, 4(3) [cit. 2021-9-25]. ISSN 2574-3805. Dostupné z: doi:10.1001/jamanetworkopen.2021.0417
  202. Anderson, M.R., Bach, P.B. & Baldwin, M.R. Hospital Length of Stay for Patients with Severe COVID-19: Implications for Remdesivir’s Value. PharmacoEconomics Open 5, 129–131 (2021). https://doi.org/10.1007/s41669-020-00243-6
  203. EPA Researchers Test Effectiveness of Face Masks, Disinfection Methods Against COVID-19. https://www.epa.gov/sciencematters/epa-researchers-test-effectiveness-face-masks-disinfection-methods-against-covid-19
  204. BRAUNER, Jan M., Sören MINDERMANN, Mrinank SHARMA, et al. Inferring the effectiveness of government interventions against COVID-19. Science [online]. 2021, 371(6531) [cit. 2021-9-25]. ISSN 0036-8075. Dostupné z: doi:10.1126/science.abd9338
  205. Scientific Brief: SARS-CoV-2 Transmission. https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/sars-cov-2-transmission.html
  206. Information for Pediatric Healthcare Providers. https://www.cdc.gov/coronavirus/2019-ncov/hcp/pediatric-hcp.html
  207. Diagnostic testing and screening for SARS-CoV-2. https://www.ecdc.europa.eu/en/covid-19/latest-evidence/diagnostic-testing
  208. ALENE, Muluneh, Leltework YISMAW, Moges Agazhe ASSEMIE, Daniel Bekele KETEMA, Belayneh MENGIST, Bekalu KASSIE, Tilahun Yemanu BIRHAN a Kin On KWOK. Magnitude of asymptomatic COVID-19 cases throughout the course of infection: A systematic review and meta-analysis. PLOS ONE [online]. 2021, 16(3) [cit. 2021-9-25]. ISSN 1932-6203. Dostupné z: doi:10.1371/journal.pone.0249090
  209. GOHIL, Shruti K., Keith OLENSLAGER, Kathleen A. QUAN, Cyrus K. DASTUR, Nasim AFSAR, Wayne CHANG a Susan S. HUANG. Asymptomatic and Symptomatic COVID-19 Infections Among Health Care Personnel Before and After Vaccination. JAMA Network Open [online]. 2021, 4(7) [cit. 2021-9-25]. ISSN 2574-3805. Dostupné z: doi:10.1001/jamanetworkopen.2021.15980
  210. LOCATELLI, Isabella, Bastien TRÄCHSEL, Valentin ROUSSON a Yury E. KHUDYAKOV. Estimating the basic reproduction number for COVID-19 in Western Europe. PLOS ONE [online]. 2021, 16(3) [cit. 2021-9-25]. ISSN 1932-6203. Dostupné z: doi:10.1371/journal.pone.0248731
  211. SALAMANNA, Francesca, Melania MAGLIO, Maria Paola LANDINI a Milena FINI. Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2. Frontiers in Medicine [online]. 2020, 7 [cit. 2021-9-25]. ISSN 2296-858X. Dostupné z: doi:10.3389/fmed.2020.594495
  212. Human mRNA vaccine trials in the 2010s? A history lesson in animal Research. https://speakingofresearch.com/2021/08/27/human-mrna-vaccine-trials-in-the-2010s-a-history-lesson-in-animal-research/
  213. Predictors of Nonseroconversion after SARS-CoV-2 Infection. https://wwwnc.cdc.gov/eid/article/27/9/21-1042_article
  214. LOGUE, Jennifer K., Nicholas M. FRANKO, Denise J. MCCULLOCH, Dylan MCDONALD, Ariana MAGEDSON, Caitlin R. WOLF a Helen Y. CHU. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Network Open [online]. 2021, 4(2) [cit. 2021-9-25]. ISSN 2574-3805. Dostupné z: doi:10.1001/jamanetworkopen.2021.0830
  215. BANERJEE, Josh, Catherine P. CANAMAR, Christian VOYAGEUR, et al. Mortality and Readmission Rates Among Patients With COVID-19 After Discharge From Acute Care Setting With Supplemental Oxygen. JAMA Network Open [online]. 2021, 4(4) [cit. 2021-9-25]. ISSN 2574-3805. Dostupné z: doi:10.1001/jamanetworkopen.2021.3990
  216. Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. Koen B. Pouwels, Emma Pritchard, Philippa C. Matthews, Nicole Stoesser, David W. Eyre, Karina-Doris Vihta, Thomas House, Jodie Hay, John I Bell, John N Newton, Jeremy Farrar, Derrick Crook, Duncan Cook, Emma Rourke, Ruth Studley, Tim Peto, Ian Diamond, A. Sarah Walker, the COVID-19 Infection Survey Team. medRxiv 2021.08.18.21262237; doi: https://doi.org/10.1101/2021.08.18.21262237
  217. Coronavirus disease (COVID-19): Herd immunity, lockdowns and COVID-19. https://www.who.int/news-room/q-a-detail/herd-immunity-lockdowns-and-covid-19
  218. Vaccine Testing and the Approval Process. https://www.cdc.gov/vaccines/basics/test-approve.html
  219. Dana, R., Bannay, A., Bourst, P. et al. Obesity and mortality in critically ill COVID-19 patients with respiratory failure. Int J Obes 45, 2028–2037 (2021). https://doi.org/10.1038/s41366-021-00872-9
  220. CHEUNG, Chun Chau Lawrence, Denise GOH, Xinru LIM, et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut [online]. , gutjnl;gutjnl-2021-324280v2 [cit. 2021-9-25]. ISSN 0017-5749. Dostupné z: doi:10.1136/gutjnl-2021-324280
  221. Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 in the UK. Nick Andrews, Elise Tessier, Julia Stowe, Charlotte Gower, Freja Kirsebom, Ruth Simmons, Eileen Gallagher, Meera Chand, Kevin Brown, Shamez N Ladhani, Mary Ramsay, Jamie Lopez Bernal. medRxiv 2021.09.15.21263583; doi: https://doi.org/10.1101/2021.09.15.21263583
  222. Ivermectin for COVID: How Do We Know What to Believe? https://www.medscape.com/viewarticle/954681
  223. GREANEY, Allison J., Andrea N. LOES, Lauren E. GENTLES, Katharine H.D. CRAWFORD, Tyler N. STARR, Keara D. MALONE, Helen Y. CHU a Jesse D. BLOOM. Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection. Science Translational Medicine [online]. 2021, 13(600) [cit. 2021-9-25]. ISSN 1946-6234. Dostupné z: doi:10.1126/scitranslmed.abi9915
  224. LÓPEZ-MEDINA, Eduardo, Pío LÓPEZ, Isabel C. HURTADO, et al. Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19. JAMA [online]. 2021, 325(14) [cit. 2021-9-25]. ISSN 0098-7484. Dostupné z: doi:10.1001/jama.2021.3071
  225. Flawed ivermectin preprint highlights challenges of COVID drug studies. https://www.nature.com/articles/d41586-021-02081-w
  226. Přednášky, včetně dosud nepublikovaných výsledků prezentovaných v průběhu ESC Congress 2021, konkrétně ze dnů 27.8.2021 a 29.8.2021, blok COVID-19.
  227. DAVID, Jan, Michaela ŠIBÍKOVÁ, Jakub JONÁŠ, Veronika STARÁ, Hana MALCOVÁ a Filip FENCL. Severe complication of COVID-19 in children: Paediatric inflammatory multisystem syndrome. Pediatrie pro praxi [online]. 2021, 22(1), 8-11 [cit. 2021-9-25]. ISSN 12130494. Dostupné z: doi:10.36290/ped.2021.001
  228. New CDC Study: Vaccination Offers Higher Protection than Previous COVID-19 Infection. https://www.cdc.gov/media/releases/2021/s0806-vaccination-protection.html
  229. MALE, Victoria. Are COVID-19 vaccines safe in pregnancy? Nature Reviews Immunology [online]. 2021, 21(4), 200-201 [cit. 2021-9-25]. ISSN 1474-1733. Dostupné z: doi:10.1038/s41577-021-00525-y
  230. KLEIN, Nicola P., Ned LEWIS, Kristin GODDARD, et al. Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA [online]. [cit. 2021-9-25]. ISSN 0098-7484. Dostupné z: doi:10.1001/jama.2021.15072
  231. ABU MOUCH, Saif, Ariel ROGUIN, Elias HELLOU, et al. Myocarditis following COVID-19 mRNA vaccination. Vaccine [online]. 2021, 39(29), 3790-3793 [cit. 2021-9-25]. ISSN 0264410X. Dostupné z: doi:10.1016/j.vaccine.2021.05.08
  232. LEVIN, Dan, Gil SHIMON, Maggie FADLON-DERAI, et al. Myocarditis following COVID-19 vaccination – A case series. Vaccine [online]. 2021 [cit. 2021-9-25]. ISSN 0264410X. Dostupné z: doi:10.1016/j.vaccine.2021.09.004
  233. SULEMANKHIL, Imran, Mohammad ABDELRAHMAN a Smita I. NEGI. Temporal association between the COVID-19 Ad26.COV2.S vaccine and acute myocarditis: A case report and literature review. Cardiovascular Revascularization Medicine [online]. 2021 [cit. 2021-9-25]. ISSN 15538389. Dostupné z: doi:10.1016/j.carrev.2021.08.012
  234. ABDELAZEEM, Basel, Mariem BORCHENI, Saed ALNAIMAT, Sagar MALLIKETHI-REDDY a Abdulbaset SULAIMAN. Persistent Cardiac Magnetic Resonance Imaging Features of Myocarditis Detected Months After COVID-19 Infection. Cureus [online]. [cit. 2021-9-25]. ISSN 2168-8184. Dostupné z: doi:10.7759/cureus.14250
  235. BLAGOVA, Olga, Dilyara AINETDINOVA, Alexey SEDOV, et al. Progressive chronic SARS‐CoV‐2‐positive giant cell myoendocarditis with atrial standstill and sudden cardiac death. ESC Heart Failure [online]. [cit. 2021-9-25]. ISSN 2055-5822. Dostupné z: doi:10.1002/ehf2.13520
  236. PIETSCH, Heiko, Felicitas ESCHER, Ganna ALESHCHEVA, Christian BAUMEIER, Lars MORAWIETZ, Albrecht ELSAESSER a Heinz-Peter SCHULTHEISS. Proof of SARS-CoV-2 genomes in endomyocardial biopsy with latency after acute infection. International Journal of Infectious Diseases [online]. 2021, 102, 70-72 [cit. 2021-9-25]. ISSN 12019712. Dostupné z: doi:10.1016/j.ijid.2020.10.012
  237. ISHIKURA, Hiroyasu, Junichi MARUYAMA, Kota HOSHINO, et al. Coronavirus disease (COVID-19) associated delayed-onset fulminant myocarditis in patient with a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Journal of Infection and Chemotherapy [online]. 2021 [cit. 2021-9-25]. ISSN 1341321X. Dostupné z: doi:10.1016/j.jiac.2021.08.007
  238. Quantifying impacts of the COVID-19 pandemic through life-expectancy losses: a population-level study of 29 countries. International Journal Of Epidemiology [online]. [cit. 2021-10-5]. ISSN 0300-5771. Dostupné z: doi:10.1093/ije/dyab207
  239. TAQUET, Maxime, Quentin DERCON, Sierra LUCIANO, John R. GEDDES, Masud HUSAIN, Paul J. HARRISON a Mirjam E. E. KRETZSCHMAR. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLOS Medicine [online]. 2021, 18(9) [cit. 2021-10-5]. ISSN 1549-1676. Dostupné z: doi:10.1371/journal.pmed.1003773
  240. BEMTGEN, Xavier, Karin KLINGEL, Markus HUFNAGEL, Ales JANDA, Christoph BODE, Dawid L. STAUDACHER, Alexander SUPADY a Ilona JANDOVA. Case Report: Lymphohistiocytic Myocarditis With Severe Cardiogenic Shock Requiring Mechanical Cardiocirculatory Support in Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection. Frontiers in Cardiovascular Medicine [online]. 2021, 8 [cit. 2021-10-5]. ISSN 2297-055X. Dostupné z: doi:10.3389/fcvm.2021.716198
  241. The use of antibody tests for SARS-COV-2 in the context of Digital Green Certificates. https://www.ecdc.europa.eu/en/publications-data/use-antibody-tests-sars-cov-2-context-digital-green-certificates
  242. Natural COVID-19 immunity is powerful — but kind of irrelevant. https://thehill.com/opinion/healthcare/574284-natural-covid-19-immunity-is-powerful-but-kind-of-irrelevant?fbclid=IwAR2FXcsE3S2A0AMMRFs5R5S9Km_7_24IEW2eESBoVbDJHz6WbcPlYg6qjOA&rl=1
  243. CASADEVALL, Arturo. The mRNA vaccine revolution is the dividend from decades of basic science research. Journal of Clinical Investigation [online]. 2021 [cit. 2021-10-5]. ISSN 1558-8238. Dostupné z: doi:10.1172/JCI153721
  244. MORAIS DA SILVA, Maríllya, André Silva LIRA DE LUCENA, Sergio de Sá Leitão PAIVA JÚNIOR, et al. Cell death mechanisms involved in cell injury caused by SARS‐CoV‐2. Reviews in Medical Virology [online]. [cit. 2021-10-5]. ISSN 1052-9276. Dostupné z: doi:10.1002/rmv.2292
  245. Studies Highlight Rarity of Myocarditis With mRNA COVID-19 Vaccines. https://www.tctmd.com/news/studies-highlight-rarity-myocarditis-mrna-covid-19-vaccines
  246. Major Israeli study: Risk of heart inflammation after COVID shots is very small. https://www.timesofisrael.com/major-israeli-study-finds-risk-of-heart-inflammation-after-covid-shots-is-minute/
  247. Heart risks rare after Pfizer Covid vaccination, study finds. https://www.nbcnews.com/health/health-news/heart-risks-rare-after-pfizer-covid-vaccination-study-finds-n1280960
  248. WITBERG, Guy, Noam BARDA, Sara HOSS, et al. Myocarditis after Covid-19 Vaccination in a Large Health Care Organization. New England Journal of Medicine [online]. [cit. 2021-10-23]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2110737
  249. MEVORACH, Dror, Emilia ANIS, Noa CEDAR, et al. Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel. New England Journal of Medicine [online]. [cit. 2021-10-23]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2109730
  250. THOMPSON, Mark G., Edward STENEHJEM, Shaun GRANNIS, et al. Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings. New England Journal of Medicine [online]. 2021, 385(15), 1355-1371 [cit. 2021-10-23]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2110362
  251. SIMONE, Anthony, John HERALD, Aiyu CHEN, Neil GULATI, Albert Yuh-Jer SHEN, Bruno LEWIN a Ming-Sum LEE. Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older. JAMA Internal Medicine [online]. [cit. 2021-10-23]. ISSN 2168-6106. Dostupné z: doi:10.1001/jamainternmed.2021.551
  252. Heart-inflammation risk from Pfizer COVID vaccine is very low. https://www.nature.com/articles/d41586-021-02740-y
  253. Sweden, Denmark pause Moderna COVID-19 vaccine for younger age groups. https://www.reuters.com/business/healthcare-pharmaceuticals/sweden-pauses-use-moderna-covid-vaccine-cites-rare-side-effects-2021-10-06/
  254. Study: For unvaccinated, reinfection by SARS-CoV-2 is likely. https://medicalxpress.com/news/2021-10-unvaccinated-reinfection-sars-cov-.html?fbclid=IwAR3AIUPhek6-ikYXwglJt_1hj4Za6FGLV5j2YhfyJX6r68oeRYU4bqIdgMo
  255. One-year Risks and Burdens of Incident Cardiovascular Disease in COVID-19: Cardiovascular Manifestations of Long COVID. Ziyad Al-Aly, Benjamin Bowe, Yan Xie, Evan Xu. DOI: 10.21203/rs.3.rs-940278/v1. https://www.researchsquare.com/article/rs-940278/v1?fbclid=IwAR044DgZ6EH6Gs26yBYbBWb5NxbhOO6F24PuuYWPzfSuFg6pgObSxyWtPDY
  256. AL-ALY, Ziyad, Yan XIE a Benjamin BOWE. High-dimensional characterization of post-acute sequelae of COVID-19. Nature [online]. 2021, 594(7862), 259-264 [cit. 2021-10-23]. ISSN 0028-0836. Dostupné z: doi:10.1038/s41586-021-03553-9
  257. TEMPLE, Courtney, Ruby HOANG a Robert G. HENDRICKSON. Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19. New England Journal of Medicine [online]. [cit. 2021-10-23]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMc2114907
  258. PFIZER AND BIONTECH ANNOUNCE PHASE 3 TRIAL DATA SHOWING HIGH EFFICACY OF A BOOSTER DOSE OF THEIR COVID-19 VACCINE. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-phase-3-trial-data-showing?fbclid=IwAR38WQA02VhQ4XDu-EA6FNn3ZvcSKY_-DDnZHShK0h_zfkI19kWE0rmJEqY
  259. Jing, Y., Luo, L., Chen, Y. et al. SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism. Sig Transduct Target Ther 6, 345 (2021). https://doi.org/10.1038/s41392-021-00749-3
  260. FALSEY, Ann R., Robert W. FRENCK, Edward E. WALSH, et al. SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3. New England Journal of Medicine [online]. 2021, 385(17), 1627-1629 [cit. 2021-10-23]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMc2113468
  261. MAGNUS, Maria C., Håkon K. GJESSING, Helena N. EIDE, Allen J. WILCOX, Deshayne B. FELL a Siri E. HÅBERG. Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage. New England Journal of Medicine [online]. [cit. 2021-10-23]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMc2114466
  262. MONGELLI, Alessia, Veronica BARBI, Michela GOTTARDI ZAMPERLA, et al. Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors. International Journal of Molecular Sciences [online]. 2021, 22(11) [cit. 2021-10-23]. ISSN 1422-0067. Dostupné z: doi:10.3390/ijms2211615
  263. Je pro naše zdraví rizikovější prodělání infekce nebo očkování? https://vedator.org/2021/09/je-pro-nase-zdravi-rizikovejsi-prodelani-infekce-nebo-ockovani/?fbclid=IwAR1emRTPZxv5JjeAW2dmpfJWps73SKuL4Z6Er_6ihS3PfOrT3qKz7nH6t70
  264. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 7 October 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/7october2021
  265. Nespoléhejte na promořování, ale zvyšujte proočkovanost proti covid-19, vzkazuje ECDC. https://www.zdravotnickydenik.cz/2021/10/nespolehejte-na-promorovani-ale-zvysujte-proockovanost-proti-covid-19-vzkazuje-ecdc/?fbclid=IwAR0KZYvNCyRrVSFgB6HRnxTnxqiUPM15oCn3wqZJnx00QHU1dYH8xcVDK6Y
  266. CASADEVALL, Arturo. The mRNA vaccine revolution is the dividend from decades of basic science research. Journal of Clinical Investigation [online]. 2021 [cit. 2021-10-23]. ISSN 1558-8238. Dostupné z: doi:10.1172/JCI153721
  267. PEEPLES, Lynne. COVID reinfections likely within one or two years, models propose. Nature [online]. , d41586-021-02825-8 [cit. 2021-10-23]. ISSN 0028-0836. Dostupné z: doi:10.1038/d41586-021-02825-8
  268. TOWNSEND, Jeffrey P, Hayley B HASSLER, Zheng WANG, et al. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study. The Lancet Microbe [online]. 2021 [cit. 2021-10-23]. ISSN 26665247. Dostupné z: doi:10.1016/S2666-5247(21)00219-6
  269. Edridge, A.W.D., Kaczorowska, J., Hoste, A.C.R. et al. Seasonal coronavirus protective immunity is short-lasting. Nat Med 26, 1691–1693 (2020). https://doi.org/10.1038/s41591-020-1083-1
  270. Alberta – Office of the Chief Medical Officer of Health Updated October 8, 2021. Myocarditis and/or Pericarditis following COVID-19 Vaccines
  271. Only 12 Children Under 15 Get Myocarditis Out of Hundreds of Thousands Vaccinated in Israel. https://www.haaretz.com/israel-news/covid-booster-side-effects-lighter-than-after-first-two-shots-israeli-data-shows-1.10256884
  272. Israel reports very few myocarditis cases after Pfizer boosters. https://www.reuters.com/world/middle-east/israel-reports-very-few-myocarditis-cases-after-pfizer-boosters-2021-10-01/
  273. 3rd vaccine dose has lowest side effect rate, Israel Health Ministry data shows. https://www.timesofisrael.com/3rd-dose-has-lowest-rate-of-side-effects-israels-health-ministry-data-shows/
  274. Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. https://www.pcronline.com/PCR-Publications/Young-EAPCI-PCR-Journal-Club/2021/Myocarditis-after-BNT162b2-mRNA-vaccine-against-Covid-19-Israel
  275. REIS, Ben Y., Noam BARDA, Michael LESHCHINSKY, Eldad KEPTEN, Miguel A. HERNÁN, Marc LIPSITCH, Noa DAGAN a Ran D. BALICER. Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents. New England Journal of Medicine [online]. [cit. 2021-10-23]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMc2114290
  276. SHEIKH, Aziz, Chris ROBERTSON a Bob TAYLOR. BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant. New England Journal of Medicine [online]. [cit. 2021-10-23]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMc2113864
  277. Vaccines and Related Biological Products Advisory Committee  October  14-15,  2021 Meeting  Booster protection across ages data from Israel Israeli MOH, Weizmann Institute of Science, Gertner Institute, Hebrew University & Technion Oct. 12th, 2021
  278. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. New England Journal of Medicine [online]. 2021, 385(9), 777-789 [cit. 2021-10-24]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2103417
  279. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. New England Journal of Medicine [online]. 2021, 385(9), 790-802 [cit. 2021-10-24]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa2105911
  280. SAYED AHMED, Hazem A, Eric MERRELL, Mansoura ISMAIL, et al. Rationales and uncertainties for aspirin use in COVID-19: a narrative review. Family Medicine and Community Health [online]. 2021, 9(2) [cit. 2021-10-24]. ISSN 2305-6983. Dostupné z: doi:10.1136/fmch-2020-000741
  281. Antithrombotic Therapy Not Warranted in COVID-19 Outpatients. https://www.medscape.com/viewarticle/961278
  282. CONNORS, Jean M., Maria M. BROOKS, Frank C. SCIURBA, et al. Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19. JAMA [online]. [cit. 2021-10-24]. ISSN 0098-7484. Dostupné z: doi:10.1001/jama.2021.17272
  283. BERWANGER, Otavio. Antithrombotic Therapy for Outpatients With COVID-19. JAMA [online]. [cit. 2021-10-24]. ISSN 0098-7484. Dostupné z: doi:10.1001/jama.2021.17460
  284. RECOVERY trial finds aspirin does not improve survival for hospitalised COVID-19 patients. https://www.nihr.ac.uk/news/recovery-trial-finds-aspirin-does-not-improve-survival-for-hospitalised-covid-19-patients/27872
  285. Antithrombotic Therapy in Patients With COVID-19. https://www.covid19treatmentguidelines.nih.gov/therapies/antithrombotic-therapy/
  286. What are the thromboembolism prevention and treatment guidelines in patients with coronavirus disease 2019 (COVID-19)? https://www.medscape.com/answers/2500114-197652/what-are-the-thromboembolism-prevention-and-treatment-guidelines-in-patients-with-coronavirus-disease-2019-covid-19
  287. Hypercoagulability in COVID-19 and post-COVID patients – characteristics and current treatment Guidelines. https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-21/hypercoagulability-in-covid-19-and-post-covid-patients-characteristics-and-cur
  288. Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), August-September 2021, the Netherlands. Brechje de Gier, Stijn Andeweg, Jantien A. Backer, RIVM COVID-19 surveillance and epidemiology team, Susan J.M. Hahné, Susan van den Hof, Hester E. de Melker, Mirjam J. Knol. doi: https://doi.org/10.1101/2021.10.14.21264959
  289. Vekaria, B., Overton, C., Wiśniowski, A. et al. Hospital length of stay for COVID-19 patients: Data-driven methods for forward planning. BMC Infect Dis 21, 700 (2021). https://doi.org/10.1186/s12879-021-06371-6
  290. Rees, E.M., Nightingale, E.S., Jafari, Y. et al. COVID-19 length of hospital stay: a systematic review and data synthesis. BMC Med 18, 270 (2020). https://doi.org/10.1186/s12916-020-01726-3
  291. LÓPEZ-CHEDA, Ana, María-Amalia JÁCOME, Ricardo CAO a Pablo M. DE SALAZAR. Estimating lengths-of-stay of hospitalised COVID-19 patients using a non-parametric model: a case study in Galicia (Spain). Epidemiology and Infection [online]. 2021, 149 [cit. 2021-10-25]. ISSN 0950-2688. Dostupné z: doi:10.1017/S0950268821000959

ZDROJE UPDATE ČLÁNKU 2023

  1. KUODI, Paul, Yanay GORELIK, Hiba ZAYYAD, et al. Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel. Npj Vaccines [online]. 2022, 7(1) [cit. 2023-01-17]. ISSN 2059-0105. Dostupné z: doi:10.1038/s41541-022-00526-5
  2. MIZRAHI, Barak, Tamar SUDRY, Natalie FLAKS-MANOV, et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ [online]. /bmj/380/bmj-2022-072529.atom [cit. 2023-01-17]. ISSN 1756-1833. Dostupné z: doi:10.1136/bmj-2022-072529
  3. AZZOLINI, Elena, Riccardo LEVI, Riccardo SARTI, Chiara POZZI, Maximiliano MOLLURA, Alberto MANTOVANI a Maria RESCIGNO. Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers. JAMA [online]. 2022, 328(7) [cit. 2023-01-17]. ISSN 0098-7484. Dostupné z: doi:10.1001/jama.2022.11691
  4. PATONE, Martina, Xue W. MEI, Lahiru HANDUNNETTHI, et al. Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex. Circulation [online]. 2022, 146(10), 743-754 [cit. 2023-01-17]. ISSN 0009-7322. Dostupné z: doi:10.1161/CIRCULATIONAHA.122.059970
  5. Think the pandemic’s over? Guess again: Year-end figures show COVID-19 tied to more deaths in 2022. https://www.cbc.ca/news/canada/manitoba/covid-deaths-analysis-1.6699040?fbclid=IwAR0K_E8xjelMxx7szA1lRv1DrHN9arm4s3VzWt4MPDN_CufjWm2KuGN98PM
  6. 2022 was Canada’s deadliest year of the COVID-19 pandemic. https://www.wsws.org/en/articles/2023/01/07/crco-j07.html?fbclid=IwAR3cpgpvGo8xNRMFUXeLJaueFnM-r-iNcrr5bTrbdRCx5Qu9fXgV5Zk9aD4
  7. Excess deaths in 2022 among worst in 50 years. https://www.bbc.com/news/health-64209221
  8. Cumulative number of COVID-19 deaths in Denmark since March 2020. https://www.statista.com/statistics/1106692/cumulative-coronavirus-deaths-in-denmark/
  9. NAVEED, Zaeema, Julia LI, James WILTON, et al. Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines. Journal of the American College of Cardiology [online]. 2022, 80(20), 1900-1908 [cit. 2023-01-17]. ISSN 07351097. Dostupné z: doi:10.1016/j.jacc.2022.08.799
  10. HEIDECKER, Bettina, Noa DAGAN, Ran BALICER, et al. Myocarditis following COVID ‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases. European Journal of Heart Failure [online]. 2022, 24(11), 2000-2018 [cit. 2023-01-17]. ISSN 1388-9842. Dostupné z: doi:10.1002/ejhf.2669
  11. VOLETI, Navya, Surya Prakash REDDY a Paddy SSENTONGO. Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine [online]. 2022, 9 [cit. 2023-01-17]. ISSN 2297-055X. Dostupné z: doi:10.3389/fcvm.2022.951314
  12. SHIYOVICH, Arthur, Ygal PLAKHT, Guy WITBERG, Amichai ROTSTEIN, Yaron AVIV, Maya WIESSMAN, Ran KORNOWSKI a Ashraf HAMDAN. Myocarditis following COVID-19 vaccination in adolescents: Cardiac magnetic resonance imaging study. Frontiers in Cardiovascular Medicine [online]. 2022, 9 [cit. 2023-01-17]. ISSN 2297-055X. Dostupné z: doi:10.3389/fcvm.2022.978592
  13. ESPOSITO, Susanna, Caterina CAMINITI, Rosanna GIORDANO, Alberto ARGENTIERO, Greta RAMUNDO a Nicola PRINCIPI. Myocarditis Following COVID-19 Vaccine Use: Can It Play a Role for Conditioning Immunization Schedules?. Frontiers in Immunology [online]. 2022, 13 [cit. 2023-01-17]. ISSN 1664-3224. Dostupné z: doi:10.3389/fimmu.2022.915580
  14. MEVORACH, Dror, Emilia ANIS, Noa CEDAR, et al. Myocarditis after BNT162b2 Vaccination in Israeli Adolescents. New England Journal of Medicine [online]. 2022, 386(10), 998-999 [cit. 2023-01-17]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMc2116999
  15. THURNER, Lorenz, Christoph KESSEL, Natalie FADLE, et al. IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination. New England Journal of Medicine [online]. 2022, 387(16), 1524-1527 [cit. 2023-01-17]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMc2205667
  16. WITBERG, Guy, Ori MAGEN, Sara HOSS, et al. Myocarditis after BNT162b2 Vaccination in Israeli Adolescents. New England Journal of Medicine [online]. 2022, 387(19), 1816-1817 [cit. 2023-01-17]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMc2207270
  17. CAFORIO, Alida L.P. Receipt of mRNA Vaccine against Covid-19 and Myocarditis. New England Journal of Medicine [online]. 2021, 385(23), 2189-2190 [cit. 2023-01-17]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMe2116493
  18. LAI, Francisco Tsz Tsun, Edward Wai Wa CHAN, Lei HUANG, et al. Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis. Journal of the American College of Cardiology [online]. 2022, 80(24), 2255-2265 [cit. 2023-01-17]. ISSN 07351097. Dostupné z: doi:10.1016/j.jacc.2022.09.049
  19. RAMAN, Betty, David A. BLUEMKE, Thomas F. LÜSCHER a Stefan NEUBAUER. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. European Heart Journal [online]. 2022, 43(11), 1157-1172 [cit. 2023-01-17]. ISSN 0195-668X. Dostupné z: doi:10.1093/eurheartj/ehac031
  20. DAVIS, Hannah E., Lisa MCCORKELL, Julia Moore VOGEL a Eric J. TOPOL. Long COVID: major findings, mechanisms and recommendations. Nature Reviews Microbiology [online]. [cit. 2023-01-17]. ISSN 1740-1526. Dostupné z: doi:10.1038/s41579-022-00846-2

Written by